Editas Medicine Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

Latest Posts

About This Stock More About This Stock
E Ford Model T And Personalized Medicine
Article By: Ketan Desai
Monday, December 11, 2017 10:35 AM EST
While technology marches on, the economics of personalized medicines just don’t add up. Will they be like costly trinkets being displayed in a museum that we can watch at a distance but not own?
In this article: JUNO, KITE, EDIT
Read
Editas Medicine, Inc., Announces Pricing Of $50 Million Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, December 6, 2017 12:25 PM EST
Editas Medicine, Inc., a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock.
In this article: EDIT
Read
HH Small Cap Biotech Stocks Soar: How Long Will Rotation Last?
Article By: Rod Raynovich
Thursday, October 5, 2017 9:06 PM EST
Speculation in small cap biotech picks up, a boon for diligent traders. ETF buying is driving all small cap and microcap stocks higher.
In this article: AVEO, ZIOP, IJS, IWC, IWM, XBI, FPRX, RXDX, XNCR, CNCR, EDIT
Read
Biotech Rally Moving Toward April Highs: ASCO And M&A Provides Underlying Support
Article By: Rod Raynovich
Wednesday, June 1, 2016 12:03 AM EST
Biotech stocks are pretty solid over two weeks probably anticipating ASCO news and helped by more M&A news. Since hitting a recent low of $258.90 on May 19 the IBB is up over 8% and 6% over five days to $279.77 yesterday.
In this article: ALNY, ARIA, ARRY, IBB, JAZZ, GILD, XBI, XLV, JUNO, ABBV, KITE, BLUE, CPXX, EDIT
Read
Intellia Jumps On CRISPR IPO Bandwagon
Article By: IPO Candy
Thursday, May 5, 2016 4:10 PM EST
Editas (EDIT) proved that investor interest in its area is high. Intellia is another high-quality player. These are really call options “worth” about $1B each right now.
In this article: NTLA, EDIT
Read

PARTNER HEADLINES

Latest Tweets for $EDIT

No tweets yet!

$EDIT

Editas Medicine, Inc., Announces Pricing Of $50 Million Offering Of Common Stock
Michael Molman 12/6/2017 5:41:11 PM

Looking forward to hearing more information about $EDIT. Company seems to operate in a very exiting and potentially fast growing new field.

1 to 1 of 1 comments